<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02505854</url>
  </required_header>
  <id_info>
    <org_study_id>CEP 104-14</org_study_id>
    <nct_id>NCT02505854</nct_id>
  </id_info>
  <brief_title>Influence of Probiotic and Symbiotic in Body Weight, Blood Sugar and Lipemia of Obese Women</brief_title>
  <official_title>Influence of Probiotic and Symbiotic in Body Weight, Blood Sugar and Lipemia of Obese Women</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universidade Federal do Rio de Janeiro</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Rio de Janeiro State Research Supporting Foundation (FAPERJ)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Universidade Federal do Rio de Janeiro</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate whether contribute with weight loss and improvement
      of blood sugar and lipemia in obese women.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      We will evaluate the effects of probiotic on anthropometric, laboratory, metabolomic, body
      and gut microbiota composition variables.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">July 2015</start_date>
  <completion_date type="Anticipated">December 2018</completion_date>
  <primary_completion_date type="Actual">December 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Evaluate the effects of probiotic and symbiotic on weight loss of women obese in baseline and after 60 days.</measure>
    <time_frame>Baseline and 60 days</time_frame>
    <description>Determine and evaluate change in this parameters after intervention.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Effect of probiotic and symbiotic on blood glucose</measure>
    <time_frame>Baseline, 60 days and 15 days after intervention conclusion</time_frame>
    <description>Determine and comparing the blood glucose before and after intevention</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Effect probiotic and symbiotic on insulin resistance by HOMA-IR calculation</measure>
    <time_frame>Baseline and 60 days</time_frame>
    <description>Compare insulin resitance before and after intervention and evaluate whether the intervention improvement in this parameter.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Effect probiotic and symbiotic on insulin sensitivity by QUICKY calculation</measure>
    <time_frame>Baseline and 60 days</time_frame>
    <description>Compare insulin sensibility before and after intervention and evaluate whether the intervention improvement in this parameter.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Effect of probiotic and symbiotic on lipemia</measure>
    <time_frame>Baseline and 60 days</time_frame>
    <description>Compare lipemia before and after intervention and evaluate whether the intervention improvement in this parameter.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Effect probiotic and symbiotic on blood pressure</measure>
    <time_frame>Baseline,60 days and 15 days after intervention conclusion</time_frame>
    <description>Determine blood pressure before and 60 days of intervention and 15 days after intervention conclusion.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Effect of probiotic and symbiotic on compoused gut microbiota</measure>
    <time_frame>Baseline, 60 days and 15 days after intervention conclusion</time_frame>
    <description>Determine and comparing the amount filos and Bifidobacterium lactist in gut microbiota</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Effect of probiotic and symbiotic on stool consitency by Bristol scale</measure>
    <time_frame>Baseline,60 days and 15 days after intervention conclusion</time_frame>
    <description>Determine and comparing the stool consistency.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Effect of probiotic and symbiotic on gastrointestinal symptons</measure>
    <time_frame>Baseline,60 days and 15 days after intervention conclusion</time_frame>
    <description>Determine gastrintestinais symptons related to the consumption of intervention.</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">32</enrollment>
  <condition>Obesity</condition>
  <arm_group>
    <arm_group_label>Probiotic</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Hypocaloric diet associated with capsule containing 1billion UFC Bifidobacterium lactis and sache of maltodextrin</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Symbiotic</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Hypocaloric diet associated with capsule containing 1billion UFC Bifidobacterium lactis and sache of fructooligosaccharide</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Hypocaloric diet associated with capsule containing 50g of gelatin and sache of maltodextrin</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Probiotic</intervention_name>
    <description>Hypocaloric diet associated with capsule containing 1billion UFC Bifidobacterium lactis and sache of maltodextrin</description>
    <arm_group_label>Probiotic</arm_group_label>
    <other_name>Bifidobacterium lactis</other_name>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Symbiotic</intervention_name>
    <description>Hypocaloric diet associated with capsule containing 1billion UFC Bifidobacterium lactis and sache of fructooligosaccharide</description>
    <arm_group_label>Symbiotic</arm_group_label>
    <other_name>Bifidobacterium lactis and fructooligosaccharide</other_name>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Hypocaloric diet associated with capsule containing 50g of gelatin and sache of maltodextrin</description>
    <arm_group_label>Placebo</arm_group_label>
    <other_name>Gelatin</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Women;

          -  Adult;

          -  Obese (BMI between 30 and 39,9 Kg/m²).

        Exclusion Criteria:

          -  Pregnancy or nursing;

          -  Smokers;

          -  Drinkers;

          -  Use of drug or phytotherapic;

          -  Diagnosis of any cronic disease;

          -  Daily consumption of yogurt.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>25 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Louise C Oliveira, MD student</last_name>
    <role>Principal Investigator</role>
    <affiliation>Universidade Federal do Rio de Janeiro</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Louise Crovesy de Oliveira</name>
      <address>
        <city>Rio de Janeiro</city>
        <zip>21</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <link>
    <url>http://www.nutricao.ufrj.br/</url>
    <description>Institute of Nutrition Josué de Castro</description>
  </link>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 16, 2015</study_first_submitted>
  <study_first_submitted_qc>July 20, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 22, 2015</study_first_posted>
  <last_update_submitted>April 30, 2018</last_update_submitted>
  <last_update_submitted_qc>April 30, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 2, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Universidade Federal do Rio de Janeiro</investigator_affiliation>
    <investigator_full_name>Louise Crovesy de Oliveira</investigator_full_name>
    <investigator_title>Master's degree</investigator_title>
  </responsible_party>
  <keyword>Obesity</keyword>
  <keyword>Probiotic</keyword>
  <keyword>Symbiotic</keyword>
  <keyword>Weight loss</keyword>
  <keyword>Gut microbiota</keyword>
  <keyword>Bifidobacterium lactis</keyword>
  <keyword>Fructooligosaccharide</keyword>
  <keyword>Blood sugar</keyword>
  <keyword>Lipemia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Body Weight</mesh_term>
    <mesh_term>Hyperlipidemias</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

